|
niraparib/abiraterone acetate Clinical Trials
1 actively recruiting trial across 1 location
Baltimore, Maryland1 trial
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
University of Maryland Greenebaum Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.